ID PD2R_HUMAN Reviewed; 359 AA. AC Q13258; G3V5L3; Q13250; Q13251; Q1ZZ52; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 2. DT 11-NOV-2015, entry version 141. DE RecName: Full=Prostaglandin D2 receptor; DE Short=PGD receptor; DE Short=PGD2 receptor; DE AltName: Full=Prostanoid DP receptor; GN Name=PTGDR; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1). RX PubMed=7642548; DOI=10.1074/jbc.270.32.18910; RA Boie Y., Sawyer N., Slipetz D.M., Metters K.M., Abramovitz M.; RT "Molecular cloning and characterization of the human prostanoid DP RT receptor."; RL J. Biol. Chem. 270:18910-18916(1995). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Small intestine; RA Martin A.L., Kaighin V.A., Aronstam R.S.; RL Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-7; GLU-198; RP ALA-301 AND GLN-332. RG SeattleSNPs variation discovery resource; RL Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12508121; DOI=10.1038/nature01348; RA Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., RA Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., RA Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., RA Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., RA Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P., RA Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N., RA Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C., RA Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S., RA Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B., RA Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M., RA Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S., RA Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D., RA Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A., RA Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M., RA Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V., RA Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., RA Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., RA Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., RA Quetier F., Waterston R., Hood L., Weissenbach J.; RT "The DNA sequence and analysis of human chromosome 14."; RL Nature 421:601-607(2003). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP TISSUE SPECIFICITY. RX PubMed=6302737; DOI=10.1016/0090-6980(83)90131-4; RA Town M.H., Casals-Stenzel J., Schillinger E.; RT "Pharmacological and cardiovascular properties of a hydantoin RT derivative, BW 245 C, with high affinity and selectivity for PGD2 RT receptors."; RL Prostaglandins 25:13-28(1983). RN [8] RP TISSUE SPECIFICITY. RX PubMed=11082108; DOI=10.1038/sj.bjp.0703686; RA Sharif N.A., Williams G.W., Davis T.L.; RT "Pharmacology and autoradiography of human DP prostanoid receptors RT using [(3)H]-BWA868C, a DP receptor-selective antagonist RT radioligand."; RL Br. J. Pharmacol. 131:1025-1038(2000). RN [9] RP INVOLVEMENT IN SUSCEPTIBILITY TO ASRT1. RX PubMed=15496624; DOI=10.1056/NEJMoa031785; RA Oguma T., Palmer L.J., Birben E., Sonna L.A., Asano K., Lilly C.M.; RT "Role of prostanoid DP receptor variants in susceptibility to RT asthma."; RL N. Engl. J. Med. 351:1752-1763(2004). CC -!- FUNCTION: Receptor for prostaglandin D2 (PGD2). The activity of CC this receptor is mainly mediated by G(s) proteins that stimulate CC adenylate cyclase, resulting in an elevation of intracellular CC cAMP. A mobilization of calcium is also observed, but without CC formation of inositol 1,4,5-trisphosphate (By similarity). CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass CC membrane protein {ECO:0000305}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q13258-1; Sequence=Displayed; CC Name=2; CC IsoId=Q13258-2; Sequence=VSP_055141, VSP_055142; CC Note=No experimental confirmation available. Derived from EST CC data.; CC -!- TISSUE SPECIFICITY: Expressed in retinal choroid, ciliary CC epithelium, longitudinal and circular ciliary muscles, iris, small CC intestine and platelet membranes. {ECO:0000269|PubMed:11082108, CC ECO:0000269|PubMed:6302737}. CC -!- DISEASE: Asthma-related traits 1 (ASRT1) [MIM:607277]: Asthma- CC related traits include clinical symptoms of asthma, such as CC coughing, wheezing, dyspnea, bronchial hyperresponsiveness as CC assessed by methacholine challenge test, serum IgE levels, atopy CC and atopic dermatitis. {ECO:0000269|PubMed:15496624}. Note=Disease CC susceptibility is associated with variations affecting the gene CC represented in this entry. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC -!- WEB RESOURCE: Name=SeattleSNPs; CC URL="http://pga.gs.washington.edu/data/apobec3f/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U31098; AAC50176.1; -; Genomic_DNA. DR EMBL; U31099; AAC50177.1; -; mRNA. DR EMBL; U31332; AAC50178.1; -; Genomic_DNA. DR EMBL; EF577397; ABQ52417.1; -; mRNA. DR EMBL; DQ418808; ABD72608.1; -; Genomic_DNA. DR EMBL; AL365475; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471078; EAW65657.1; -; Genomic_DNA. DR EMBL; BC040968; AAH40968.1; -; mRNA. DR CCDS; CCDS61454.1; -. [Q13258-2] DR CCDS; CCDS9707.1; -. [Q13258-1] DR PIR; I39153; I39153. DR RefSeq; NP_000944.1; NM_000953.2. [Q13258-1] DR RefSeq; NP_001268398.1; NM_001281469.1. [Q13258-2] DR RefSeq; XP_005267948.1; XM_005267891.2. [Q13258-1] DR UniGene; Hs.306831; -. DR ProteinModelPortal; Q13258; -. DR SMR; Q13258; 117-148. DR BioGrid; 111701; 6. DR STRING; 9606.ENSP00000303424; -. DR BindingDB; Q13258; -. DR ChEMBL; CHEMBL4427; -. DR DrugBank; DB00716; Nedocromil. DR GuidetoPHARMACOLOGY; 338; -. DR BioMuta; PTGDR; -. DR DMDM; 2495009; -. DR PaxDb; Q13258; -. DR PRIDE; Q13258; -. DR Ensembl; ENST00000306051; ENSP00000303424; ENSG00000168229. [Q13258-1] DR Ensembl; ENST00000553372; ENSP00000452408; ENSG00000168229. [Q13258-2] DR GeneID; 5729; -. DR KEGG; hsa:5729; -. DR UCSC; uc001wzq.3; human. [Q13258-1] DR CTD; 5729; -. DR GeneCards; PTGDR; -. DR HGNC; HGNC:9591; PTGDR. DR MIM; 604687; gene. DR MIM; 607277; phenotype. DR neXtProt; NX_Q13258; -. DR PharmGKB; PA285; -. DR eggNOG; KOG3656; Eukaryota. DR eggNOG; ENOG410XRW9; LUCA. DR GeneTree; ENSGT00760000119188; -. DR HOGENOM; HOG000115475; -. DR HOVERGEN; HBG003074; -. DR InParanoid; Q13258; -. DR KO; K04332; -. DR OMA; AYYGAFK; -. DR OrthoDB; EOG72VH6G; -. DR PhylomeDB; Q13258; -. DR TreeFam; TF324982; -. DR Reactome; R-HSA-391908; Prostanoid ligand receptors. DR Reactome; R-HSA-418555; G alpha (s) signalling events. DR GeneWiki; Prostaglandin_D2_receptor; -. DR GenomeRNAi; 5729; -. DR NextBio; 22286; -. DR PRO; PR:Q13258; -. DR Proteomes; UP000005640; Chromosome 14. DR Bgee; Q13258; -. DR CleanEx; HS_PTGDR; -. DR Genevisible; Q13258; HS. DR GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL. DR GO; GO:0004956; F:prostaglandin D receptor activity; NAS:UniProtKB. DR GO; GO:0001785; F:prostaglandin J receptor activity; IEA:Ensembl. DR GO; GO:0046085; P:adenosine metabolic process; IEA:Ensembl. DR GO; GO:0071799; P:cellular response to prostaglandin D stimulus; IEA:Ensembl. DR GO; GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB. DR GO; GO:0006954; P:inflammatory response; IEA:Ensembl. DR GO; GO:0030238; P:male sex determination; IEA:Ensembl. DR GO; GO:0030431; P:sleep; IEA:Ensembl. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR000376; Pglndn_D_rcpt. DR InterPro; IPR008365; Prostanoid_rcpt. DR PANTHER; PTHR11866; PTHR11866; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR01788; PROSTANOIDR. DR PRINTS; PR00854; PRSTNOIDDPR. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. PE 2: Evidence at transcript level; KW Alternative splicing; Asthma; Cell membrane; Complete proteome; KW Disulfide bond; G-protein coupled receptor; Glycoprotein; Membrane; KW Polymorphism; Receptor; Reference proteome; Transducer; Transmembrane; KW Transmembrane helix. FT CHAIN 1 359 Prostaglandin D2 receptor. FT /FTId=PRO_0000070047. FT TOPO_DOM 1 21 Extracellular. {ECO:0000255}. FT TRANSMEM 22 42 Helical; Name=1. {ECO:0000255}. FT TOPO_DOM 43 59 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 60 80 Helical; Name=2. {ECO:0000255}. FT TOPO_DOM 81 107 Extracellular. {ECO:0000255}. FT TRANSMEM 108 128 Helical; Name=3. {ECO:0000255}. FT TOPO_DOM 129 150 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 151 171 Helical; Name=4. {ECO:0000255}. FT TOPO_DOM 172 195 Extracellular. {ECO:0000255}. FT TRANSMEM 196 216 Helical; Name=5. {ECO:0000255}. FT TOPO_DOM 217 262 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 263 283 Helical; Name=6. {ECO:0000255}. FT TOPO_DOM 284 310 Extracellular. {ECO:0000255}. FT TRANSMEM 311 331 Helical; Name=7. {ECO:0000255}. FT TOPO_DOM 332 359 Cytoplasmic. {ECO:0000255}. FT CARBOHYD 10 10 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 90 90 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 297 297 N-linked (GlcNAc...). {ECO:0000255}. FT DISULFID 105 183 {ECO:0000255|PROSITE-ProRule:PRU00521}. FT VAR_SEQ 283 296 YRAYYGAFKDVKEK -> AFVPGVPAKTPGSR (in FT isoform 2). {ECO:0000305}. FT /FTId=VSP_055141. FT VAR_SEQ 297 359 Missing (in isoform 2). {ECO:0000305}. FT /FTId=VSP_055142. FT VARIANT 7 7 R -> C (in dbSNP:rs41311442). FT {ECO:0000269|Ref.3}. FT /FTId=VAR_033482. FT VARIANT 198 198 G -> E (in dbSNP:rs41312444). FT {ECO:0000269|Ref.3}. FT /FTId=VAR_054975. FT VARIANT 301 301 E -> A (in dbSNP:rs41312504). FT {ECO:0000269|Ref.3}. FT /FTId=VAR_033483. FT VARIANT 332 332 R -> Q (in dbSNP:rs41312506). FT {ECO:0000269|Ref.3}. FT /FTId=VAR_054976. SQ SEQUENCE 359 AA; 40271 MW; 098F89F08D0BE12A CRC64; MKSPFYRCQN TTSVEKGNSA VMGGVLFSTG LLGNLLALGL LARSGLGWCS RRPLRPLPSV FYMLVCGLTV TDLLGKCLLS PVVLAAYAQN RSLRVLAPAL DNSLCQAFAF FMSFFGLSST LQLLAMALEC WLSLGHPFFY RRHITLRLGA LVAPVVSAFS LAFCALPFMG FGKFVQYCPG TWCFIQMVHE EGSLSVLGYS VLYSSLMALL VLATVLCNLG AMRNLYAMHR RLQRHPRSCT RDCAEPRADG REASPQPLEE LDHLLLLALM TVLFTMCSLP VIYRAYYGAF KDVKEKNRTS EEAEDLRALR FLSVISIVDP WIFIIFRSPV FRIFFHKIFI RPLRYRSRCS NSTNMESSL //